Table 4.

Comparison of SCORE2 and SCORE2-OP values between patients and controls in age categories and between groups according to sex, PASI and type of psoriasis.

		Psoriasis Patients		Difference Test		Controls		Difference Test
		n	Mean ± SD	U Value	p Value	n	Mean ± SD	U Value	p Value
Gender
<50 years	male	40	3.11 ± 2.29	369.500	<0.001	17	1.85 ± 0.95	153.500	0.046
	female	35	1.90 ± 2.34			27	1.54 ± 1.04
50–69 years	male	18	9.22 ± 3.68	121.500	0.087	9	5.61 ± 2.80	52.500	0.688
	female	20	7.38 ± 4.86			13	7.54 ± 6.52
>70 years	male	1	16.00	0.000	0.317	0
	female	1	23.00			0
PASI
<50 years	PASI < 10	17	1.464 ± 0.8652	242.500	0.21
	PASI > 10	57	2.821 ± 2.5997
50–69 years	PASI < 10	11	5.875 ± 4.1469	67.500	0.73
	PASI > 10	29	8.897 ± 4.3597
>70 years	PASI < 10	2	23.000
Psoriasis type
<50 years	type I	52	3.24 ± 2.68	27.000	0.343
	type II	23	1.50 ± 0.71
50–69 years	type I	20	8.37 ± 5.12	169.500	0.964
	type II	18	7.86 ± 3.53
>70 years	type I	0
	type II	2	19.50 ± 4.95